Trade Filings
Managers Aandelen Ingediende stukken Superinvesteerders
Signalen Institutionele aankopen Institutionele verkopen Insider-activiteit 13D & 13G Watch Sectorrotatie
Tools Aandelenscreener Manager Screener Beheerders vergelijken Consensusmandjes Alle onderzoekstools Data-API
Leren & AI Leren Vraag de data AI-agents
Nieuws ★ Opgeslagen
Over Over ons Methodologie Contact Disclaimer
Reader
DATAPAKKETTEN

Downloads van historische gegevens — beschikbaar met accounts.

API GATEWAY

Gratis alleen-lezen JSON-toegang tot de gecachede gegevens van de site.

Donkere modus

🧭 Begeleide weergave
Nieuw met markten — koersen, yields, YTD, marktkapitalisatie? We leggen elk begrip uit terwijl u bladert, in begrijpelijke taal. Dezelfde data, met ingebouwde uitleg.

⚡ Expertvisie
U kent de markt al. Alleen de data — schoon, snel en compact, zonder extra uitleg. Dit is de standaardweergave.

Interfacetaal
Effectdossier

TMO

Thermo Fisher Scientific Inc. · Healthcare · Medical - Diagnostics & Research

628.15 -0.1% marktkapitalisatie $233.43B koers vertraagd (FMP) · per Aug 25 22:08 UTC — los van onderstaande aangiftegegevens

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024
191Gevolgde houders
+3Δ houders
260.61MGehouden aandelen
$131.45BGerapporteerde waarde
+5Nieuwe posities
−1Uitstappen
Stable Overtuigingsscore 43/100 Hoe deze worden berekend → Dit toelichten aan de Research Desk →

Momentum-inputs (vergelijkbare managers): breedte van houders +1.6% · aandelenstroom +0.3% · netto nieuwe posities +2.1%formule
Brede accumulatie — stijgende aandelen bij meer houders

Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2026

Eigendom in de tijd
KwartaalHoudersΔAandelenGerapporteerde waardeNieuwUitstappen
Q2 2026 191 +3 260.61M $131.45B +5 −1
Q1 2026 190 +2 255.88M $126.62B +7 −6
Q4 2025 187 +3 274.75M $159.19B +4
Q3 2025 29 -1 154.46M $74.90B +1 −3
Q2 2025 28 +3 123.95M $50.25B +3
Q1 2025 22 -2 60.64M $30.17B −2
Q4 2024 24 +2 61.50M $31.99B +2
Q3 2024 21 -2 44.46M $27.48B −2
Q2 2024 23 44.78M $24.75B
Aantal houders
Wie het bezit · Q2 2026
#ManagerAandelenΔ aandelenWaardeHun gewichtGehouden
1 State Street Global Advisors (passief) 16.83M +0.6% $8.44B 0.3% ▲ Add 7 SEC ↗
2 Fidelity (FMR) 14.08M +30.7% $7.06B 0.3% ▲ Add 5 SEC ↗
3 Fidelity (FMR) 14.08M +30.7% $7.06B 0.3% ▲ Add 5 SEC ↗
4 Fidelity (FMR) 14.08M +30.7% $7.06B 0.3% ▲ Add 5 SEC ↗
5 Fidelity (FMR) 14.08M +30.7% $7.06B 0.3% ▲ Add 5 SEC ↗
6 Fidelity (FMR) 14.08M +30.7% $7.06B 0.3% ▲ Add 5 SEC ↗
7 Fidelity (FMR) 14.08M +30.7% $7.06B 0.3% ▲ Add 5 SEC ↗
8 Fidelity (FMR) 14.08M +30.7% $7.06B 0.3% ▲ Add 5 SEC ↗
9 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
10 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
11 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
12 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
13 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
14 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
15 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
16 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
17 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
18 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
19 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
20 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
21 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
22 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
23 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
24 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
25 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
26 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
27 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
28 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
29 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
30 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
31 Morgan Stanley 10.76M -0.9% $5.40B 0.3% ▼ Trim 4 SEC ↗
32 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
33 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
34 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
35 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
36 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
37 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
38 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
39 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
40 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
41 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
42 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
43 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
44 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
45 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
46 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
47 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
48 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
49 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
50 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
51 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
52 JPMorgan Chase 8.50M +25.1% $4.31B 0.3% ▲ Add 4 SEC ↗
53 Franklin Resources Inc 7.27M +6.7% $3.65B 0.8% ▲ Add 3 SEC ↗
54 Franklin Resources Inc 7.27M +6.7% $3.65B 0.8% ▲ Add 3 SEC ↗
55 Franklin Resources Inc 7.27M +6.7% $3.65B 0.8% ▲ Add 3 SEC ↗
56 Franklin Resources Inc 7.27M +6.7% $3.65B 0.8% ▲ Add 3 SEC ↗
57 Franklin Resources Inc 7.27M +6.7% $3.65B 0.8% ▲ Add 3 SEC ↗
58 Franklin Resources Inc 7.27M +6.7% $3.65B 0.8% ▲ Add 3 SEC ↗
59 Franklin Resources Inc 7.27M +6.7% $3.65B 0.8% ▲ Add 3 SEC ↗
60 Franklin Resources Inc 7.27M +6.7% $3.65B 0.8% ▲ Add 3 SEC ↗
61 Franklin Resources Inc 7.27M +6.7% $3.65B 0.8% ▲ Add 3 SEC ↗
62 Franklin Resources Inc 7.27M +6.7% $3.65B 0.8% ▲ Add 3 SEC ↗
63 Franklin Resources Inc 7.27M +6.7% $3.65B 0.8% ▲ Add 3 SEC ↗
64 Franklin Resources Inc 7.27M +6.7% $3.65B 0.8% ▲ Add 3 SEC ↗
65 Franklin Resources Inc 7.27M +6.7% $3.65B 0.8% ▲ Add 3 SEC ↗
66 Franklin Resources Inc 7.27M +6.7% $3.65B 0.8% ▲ Add 3 SEC ↗
67 T. Rowe Price 5.12M -19.0% $2.57B 0.3% ▼ Trim 9 SEC ↗
68 T. Rowe Price 5.12M -19.0% $2.57B 0.3% ▼ Trim 9 SEC ↗
69 Massachusetts Financial Services Co… 2.97M -1.6% $2.28B 0.7% ▼ Trim 3 SEC ↗
70 Massachusetts Financial Services Co… 2.97M -1.6% $2.28B 0.7% ▼ Trim 3 SEC ↗
71 Massachusetts Financial Services Co… 2.97M -1.6% $2.28B 0.7% ▼ Trim 3 SEC ↗
72 Massachusetts Financial Services Co… 2.97M -1.6% $2.28B 0.7% ▼ Trim 3 SEC ↗
73 Massachusetts Financial Services Co… 2.97M -1.6% $2.28B 0.7% ▼ Trim 3 SEC ↗
74 Massachusetts Financial Services Co… 2.97M -1.6% $2.28B 0.7% ▼ Trim 3 SEC ↗
75 Massachusetts Financial Services Co… 2.97M -1.6% $2.28B 0.7% ▼ Trim 3 SEC ↗
76 Massachusetts Financial Services Co… 2.97M -1.6% $2.28B 0.7% ▼ Trim 3 SEC ↗
77 Massachusetts Financial Services Co… 2.97M -1.6% $2.28B 0.7% ▼ Trim 3 SEC ↗
78 Bank Of America Corp /De/ 3.90M -29.6% $1.95B 0.1% ▼ Trim 3 SEC ↗
79 Bank Of America Corp /De/ 3.90M -29.6% $1.95B 0.1% ▼ Trim 3 SEC ↗
80 Bank Of America Corp /De/ 3.90M -29.6% $1.95B 0.1% ▼ Trim 3 SEC ↗
81 Bank Of America Corp /De/ 3.90M -29.6% $1.95B 0.1% ▼ Trim 3 SEC ↗
82 Bank Of America Corp /De/ 3.90M -29.6% $1.95B 0.1% ▼ Trim 3 SEC ↗
83 Bank Of America Corp /De/ 3.90M -29.6% $1.95B 0.1% ▼ Trim 3 SEC ↗
84 Bank Of America Corp /De/ 3.90M -29.6% $1.95B 0.1% ▼ Trim 3 SEC ↗
85 Bank Of America Corp /De/ 3.90M -29.6% $1.95B 0.1% ▼ Trim 3 SEC ↗
86 Northern Trust Corp 3.33M -2.5% $1.67B 0.2% ▼ Trim 3 SEC ↗
87 Northern Trust Corp 3.33M -2.5% $1.67B 0.2% ▼ Trim 3 SEC ↗
88 Northern Trust Corp 3.33M -2.5% $1.67B 0.2% ▼ Trim 3 SEC ↗
89 Northern Trust Corp 3.33M -2.5% $1.67B 0.2% ▼ Trim 3 SEC ↗
90 Northern Trust Corp 3.33M -2.5% $1.67B 0.2% ▼ Trim 3 SEC ↗
91 Northern Trust Corp 3.33M -2.5% $1.67B 0.2% ▼ Trim 3 SEC ↗
92 Northern Trust Corp 3.33M -2.5% $1.67B 0.2% ▼ Trim 3 SEC ↗
93 Northern Trust Corp 3.33M -2.5% $1.67B 0.2% ▼ Trim 3 SEC ↗
94 Northern Trust Corp 3.33M -2.5% $1.67B 0.2% ▼ Trim 3 SEC ↗
95 Northern Trust Corp 3.33M -2.5% $1.67B 0.2% ▼ Trim 3 SEC ↗
96 Charles Schwab Investment… 3.11M +6.1% $1.56B 0.2% ▲ Add 3 SEC ↗
97 Charles Schwab Investment… 3.11M +6.1% $1.56B 0.2% ▲ Add 3 SEC ↗
98 Dodge & Cox 3.05M +11767.4% $1.53B 0.8% ▲ Add 9 SEC ↗
99 Goldman Sachs Group 2.96M -6.3% $1.48B 0.2% ▼ Trim 4 SEC ↗
100 Goldman Sachs Group 2.96M -6.3% $1.48B 0.2% ▼ Trim 4 SEC ↗

"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.

Nieuwe kopers

Geen nieuwe bijgehouden kopers dit kwartaal.

Verlaten

Geen bijgehouden uitstappen dit kwartaal.

Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 24.30K aandelen, $11,944 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.

Vaak gezamenlijk in bezit

Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.

Insider-transacties

Open-market aankopen (P)

Geen open-market insider-aankopen in ons dekkingsvenster.

Open-market verkopen (S)

Aug 21 CASPER MARC N

Officer, Director · 321 aand · $201,941

Aug 21 CASPER MARC N

Officer, Director · 3.01K aand · $1.89M

Aug 21 CASPER MARC N

Officer, Director · 1.79K aand · $1.12M

Aug 21 CASPER MARC N

Officer, Director · 2.15K aand · $1.35M

Aug 21 CASPER MARC N

Officer, Director · 2.73K aand · $1.71M

Aug 20 CASPER MARC N

Officer, Director · 560 aand · $354,446

Aug 20 CASPER MARC N

Officer, Director · 80 aand · $50,719

Aug 20 CASPER MARC N

Officer, Director · 1.31K aand · $824,745

Aug 20 CASPER MARC N

Officer, Director · 2.60K aand · $1.64M

Aug 20 CASPER MARC N

Officer, Director · 1.25K aand · $787,312

Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie

Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR. Rapportageperiode: Q2 2026 · Methodologie · Verkrijg dit via de API